Jaimy Lee's profile photo

Jaimy Lee

New York

Deputy Editor, Newsletters at Endpoints News

Deputy editor @endpts. Alum: @MarketWatch, @LinkedIn

Featured in: Favicon endpts.com Favicon linkedin.com Favicon msn.com Favicon wsj.com Favicon yahoo.com (+1) Favicon marketwatch.com Favicon barrons.com Favicon morningstar.com Favicon campaignlive.co.uk Favicon prweek.com

Articles

  • MoonLake discloses up to $500M in financing; OSR’s deal with innovation fund

    3 weeks ago | endpts.com | Jaimy Lee

    MoonLake Immunotherapeutics gets financing worth up to $500M: The company will get $75 million upfront from Hercules Capital. MoonLake, which went …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

  • Acelyrin, Pliant turn to ‘poison pill’ as Kevin Tang’s Concentra pursues both companies

    1 month ago | endpts.com | Jaimy Lee

    Acelyrin and Pliant Therapeutics, both of which are viewed as takeover targets for Kevin Tang’s Concentra Biosciences, each adopted a “poison pill” on Thursday morning …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

  • Akero, 89bio disclose public offerings; BioAge drops Phase 2 obesity drug

    2 months ago | endpts.com | Jaimy Lee

    Plus, news about Vigonvita Life Sciences and Lutris Pharma:For MASH developers, a race for cash: Akero Therapeutics aims to raise …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

  • Can the Pfizer machine fight back against an activist investor?

    Jan 14, 2025 | endpts.com | Jaimy Lee

    After a tumultuous 2024 filled with more cost cuts, an activist investor, a …Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

  • Applied Therapeutics’ rare disease drug gets a CRL

    Nov 27, 2024 | endpts.com | Jaimy Lee |Lei Lei Wu

    The FDA rejected Applied Therapeutics’ experimental treatment for a rare disease called classic galactosemia, citing deficiencies with the application. The company, while “disappointed with the … Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
4K
Tweets
2K
DMs Open
No
Jaimy Lee
Jaimy Lee @jaimy_lee
8 Jan 25

So excited that @alexis_s_kramer has joined @endpts to steer our pharma coverage! She has a decade of experience covering law at Bloomberg Law, including working on stories about how various Trump drug pricing regulations were challenged in court. https://t.co/YBgTVl6h8v

Jaimy Lee
Jaimy Lee @jaimy_lee
19 Jul 24

RT @stefaniei: This is a travesty. #IStandWithEvan #JournalismIsNotACrime https://t.co/jSysZrWZEw via @WSJ

Jaimy Lee
Jaimy Lee @jaimy_lee
17 Apr 24

As ivermectin moves back into the news cycle, my story tracing the faulty science that led to the idea the drug successfully treats Covid: https://t.co/4n0AWZYROP